151 related articles for article (PubMed ID: 36155284)
1. Corrigendum to "2', 4'-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg". [Int. Immunopharmacol. 108 (2022) 108769].
Qi WH; Zhang YY; Xing K; Hao DX; Zhang F; Wang RN; Bao MY; Tian MY; Yang YN; Li X; Zhang Y
Int Immunopharmacol; 2022 Nov; 112():109259. PubMed ID: 36155284
[No Abstract] [Full Text] [Related]
2. 2', 4'-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg.
Qi WH; Zhang YY; Xing K; Hao DX; Zhang F; Wang RN; Bao MY; Tian MY; Yang YN; Li X; Zhang Y
Int Immunopharmacol; 2022 Jul; 108():108769. PubMed ID: 35453073
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist.
Shibata A; Uga K; Sato T; Sagara M; Igaki K; Nakamura Y; Ochida A; Kono M; Shirai J; Yamamoto S; Yamasaki M; Tsuchimori N
Biochem Pharmacol; 2018 Apr; 150():35-45. PubMed ID: 29369782
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to "Mangiferin corrects the imbalance of Th17/Treg cells in mice with TNBS-induced colitis" [Int. Immunopharmacol. (2016) 220-228].
Lim SM; Jeong JJ; Choi HS; Chang HB; Kim DH
Int Immunopharmacol; 2016 Sep; 38():468. PubMed ID: 27262502
[No Abstract] [Full Text] [Related]
5. Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer.
Chellappa S; Hugenschmidt H; Hagness M; Line PD; Labori KJ; Wiedswang G; Taskén K; Aandahl EM
Oncoimmunology; 2016 Apr; 5(4):e1102828. PubMed ID: 27141387
[TBL] [Abstract][Full Text] [Related]
6. LncRNA-MEG3 functions as a competing endogenous RNA to regulate Treg/Th17 balance in patients with asthma by targeting microRNA-17/ RORγt.
Qiu YY; Wu Y; Lin MJ; Bian T; Xiao YL; Qin C
Biomed Pharmacother; 2019 Mar; 111():386-394. PubMed ID: 30594051
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo.
Guendisch U; Weiss J; Ecoeur F; Riker JC; Kaupmann K; Kallen J; Hintermann S; Orain D; Dawson J; Billich A; Guntermann C
PLoS One; 2017; 12(11):e0188391. PubMed ID: 29155882
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Evaluation of TAK-828F, a Novel Orally Available RORγt Inverse Agonist, on Murine Colitis Model.
Igaki K; Nakamura Y; Komoike Y; Uga K; Shibata A; Ishimura Y; Yamasaki M; Tsukimi Y; Tsuchimori N
Inflammation; 2019 Feb; 42(1):91-102. PubMed ID: 30121880
[TBL] [Abstract][Full Text] [Related]
9. Potent Antagonists of RORγt, Cardenolides from Calotropis gigantea, Exhibit Discrepant Effects on the Differentiation of T Lymphocyte Subsets.
Liu J; Bai LP; Yang F; Yao X; Lei K; Kei Lam CW; Wu Q; Zhuang Y; Xiao R; Liao K; Kuok H; Li T; Liu L
Mol Pharm; 2019 Feb; 16(2):798-807. PubMed ID: 30592425
[TBL] [Abstract][Full Text] [Related]
10. The effect of 6-gingerol on inflammatory response and Th17/Treg balance in DSS-induced ulcerative colitis mice.
Sheng Y; Wu T; Dai Y; Ji K; Zhong Y; Xue Y
Ann Transl Med; 2020 Apr; 8(7):442. PubMed ID: 32395486
[TBL] [Abstract][Full Text] [Related]
11. [Role of Imbalance between Th17 Cells and Treg Cells in the Pathogenesis of Children with Henoch-Schonlein Purpura].
Wang Q; Shi YY; Cao M; Dong W; Zhang JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1391-6. PubMed ID: 26524044
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum to "Small extracellular vesicles derived from human mesenchymal stem cells prevent Th17-dominant neutrophilic airway inflammation via immunoregulation on Th17 cells" [Int. Immunopharmacol. 133 (2024) 112126].
He BX; Fang SB; Xie YC; Lou DX; Wu ZC; Li CG; Liu XQ; Zhou ZR; Huang LX; Tian T; Chen DH; Fu QL
Int Immunopharmacol; 2024 Jun; 134():112339. PubMed ID: 38796405
[No Abstract] [Full Text] [Related]
13. Upregulated Expression of microRNA-16 Correlates with Th17/Treg Cell Imbalance in Patients with Rheumatoid Arthritis.
Wu YH; Liu W; Xue B; Zhang L; Liu XY; Liu B; Wang Y; Cai Y; Duan R
DNA Cell Biol; 2016 Dec; 35(12):853-860. PubMed ID: 27875659
[TBL] [Abstract][Full Text] [Related]
14. Lower T Regulatory and Th17 Cell Populations Predicted by RT-PCR-Amplified
Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Ou LS; Yao TC; Jaing TH; Shih YF; Wu CY
Front Immunol; 2020; 11():1111. PubMed ID: 32670274
[TBL] [Abstract][Full Text] [Related]
15. Madecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARγ/AMPK/ACC1 pathway.
Xu X; Wang Y; Wei Z; Wei W; Zhao P; Tong B; Xia Y; Dai Y
Cell Death Dis; 2017 Mar; 8(3):e2723. PubMed ID: 28358365
[TBL] [Abstract][Full Text] [Related]
16. Sodium houttuynia alleviates airway inflammation in asthmatic mice by regulating FoxP3/RORγT expression and reversing Treg/Th17 cell imbalance.
Wang C; Huang CF; Li M
Int Immunopharmacol; 2022 Feb; 103():108487. PubMed ID: 34959187
[TBL] [Abstract][Full Text] [Related]
17. Altered Expression of Specific Transcription Factors of Th17 (RORγt, RORα) and Treg Lymphocytes (FOXP3) by Peripheral Blood Mononuclear Cells from Patients with Multiple Sclerosis.
Etesam Z; Nemati M; Ebrahimizadeh MA; Ebrahimi HA; Hajghani H; Khalili T; Frootan R; Zinoddini N; Jafarzadeh A
J Mol Neurosci; 2016 Sep; 60(1):94-101. PubMed ID: 27370539
[TBL] [Abstract][Full Text] [Related]
18. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-221-5p suppressed the Th17/Treg ratio in asthma via RORγt/Foxp3 by targeting SOCS1.
Guan Y; Ma Y; Tang Y; Liu X; Zhao Y; An L
Allergy Asthma Clin Immunol; 2021 Dec; 17(1):123. PubMed ID: 34863307
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol Unbound RORγt Protein Enables a Sensitive Inverse Agonist Screening.
Koyama R; Fukuda Y; Kamada Y; Nakagawa H; Witmer D; Ambrus-Aikelin G; Sang BC; Nakayama M; Iwata H
Assay Drug Dev Technol; 2018; 16(4):194-204. PubMed ID: 29874096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
